Evidence map›Paper›PMID 33968001›Full record

ArticleFrontiers in microbiology2021

Disruption of the MreB Elongasome Is Overcome by Mutations in the Tricarboxylic Acid Cycle.

Brody Barton, Addison Grinnell, Randy M Morgenstein

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Genetic basis of cefiderocol resistance inMicrobiology spectrum · 2026
    Article
  3. Review
  4. Article
  5. Adaptation ofMicroorganisms · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brody BartonDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, United States.
Addison GrinnellDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, United States.
Randy M MorgensteinDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, United States.
Oklahoma State University · US

Funding

Beyond cell shape: A novel role for the bacterial actin MreB in chemotaxisR15GM129636 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI MORGENSTEIN, RANDY M · 2020 to 2023
$875k
NIGMS NIH HHS R15 GM129636
6 · The paper itself

Abstract

The bacterial actin homolog, MreB, is highly conserved among rod-shaped bacteria and essential for growth under normal growth conditions. MreB directs the localization of cell wall synthesis and loss of MreB results in round cells and death. Using the MreB depolymerizing drug, A22, we show that changes to central metabolism through deletion of malate dehydrogenase from the tricarboxylic acid (TCA) cycle results in cells with an increased tolerance to A22. We hypothesize that deletion of malate dehydrogenase leads to the upregulation of gluconeogenesis resulting in an increase in cell wall precursors. Consistent with this idea, metabolite analysis revealed that malate dehydrogenase (mdh) deletion cells possess elevated levels of several glycolysis/gluconeogenesis compounds and the cell wall precursor, uridine diphosphate N-acetylglucosamine (UDP-NAG). In agreement with these results, the increased A22 resistance phenotype can be recapitulated through the addition of glucose to the media. Finally, we show that this increase in antibiotic tolerance is not specific to A22 but also applies to the cell wall-targeting antibiotic, mecillinam.

Indexed as

antibiotic resistanceelongasomegluconeogenesisMreB cytoskeletontricarboxylic acid cycle

Identifiers

PMID33968001
PMCPMC8102728
OpenAlexW3158398109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.